Institutions / Victory Capital Management, Inc. / Activity
Activity — Victory Capital Management, Inc.
2,421 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Add | G61188101 Common stock | $5.6K | +491 +1.47% | 33,807 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Ocular Therapeutix, Inc Common stock | $5.6K | +570 +2.53% | 23,098 <0.01% of portfolio | low |
| Q2 2026 as of | Add | G1144A105 Common stock | $5.7K | +3K +8.63% | 39,598 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Quantum Computing Inc. Common stock | $5.7K | +584 +2.59% | 23,164 <0.01% of portfolio | low |
| Q2 2026 as of | Add | 10x Genomics, Inc. Common stock | $5.7K | +148 +1.15% | 13,041 <0.01% of portfolio | low |
| Q2 2026 as of | Add | C3.ai, Inc. Common stock | $5.7K | +627 +4.25% | 15,394 <0.01% of portfolio | low |
| Q2 2026 as of | Add | ThredUp Inc. Common stock | $5.7K | +833 +7.62% | 11,771 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Sarepta Therapeutics, Inc. Common stock | $5.7K | +319 +1.96% | 16,585 <0.01% of portfolio | low |
| Q2 2026 as of | Add | V. F. Corporation Common stock | $5.7K | +344 +0.60% | 57,451 <0.01% of portfolio | low |
| Q2 2026 as of | Add | RXT Rackspace Technology, Inc. Common Stock | $5.7K | +879 +7.85% | 12,073 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Iradimed Corporation Common stock | $5.8K | +61 +0.23% | 26,143 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Pathward Financial Inc Common stock | $5.9K | +66 +1.08% | 6,149 <0.01% of portfolio | low |
| Q1 2026 as of | Add | DVLT Datavault AI Inc. Common Stock | $5.9K | +10K +35.25% | 36,909 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Richtech Robotics Inc. Common stock | $6.0K | +3K +16.18% | 20,589 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Tarsus Pharmaceuticals, Inc. Common stock | $6.0K | +96 +2.10% | 4,667 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Healthcare Realty Trust Inc Common stock | $6.1K | +301 +0.55% | 55,490 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Uranium Energy Corp Common stock | $6.1K | +450 +0.82% | 55,094 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Absci Corp Common stock | $6.2K | +536 +0.35% | 151,535 <0.01% of portfolio | low |
| Q2 2026 as of | Add | DDD 3D Systems Corp Common Stock | $6.3K | +2K +13.02% | 18,093 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Vistance Networks, Inc. Common stock | $6.3K | +348 +1.42% | 24,829 <0.01% of portfolio | low |
| Q2 2026 as of | Add | IBRX ImmunityBio, Inc. Common Stock | $6.3K | +724 +1.69% | 43,486 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Getty Realty Corp Common stock | $6.4K | +200 +2.34% | 8,739 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Calumet, Inc. /DE Common stock | $6.4K | +177 +2.29% | 7,912 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Caris Life Sciences, Inc. Common stock | $6.4K | +359 +2.60% | 14,161 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Liberty Live Holdings, Inc. Common stock | $6.4K | +61 +0.64% | 9,604 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Viking Therapeutics Inc Common stock | $6.5K | +199 +1.57% | 12,846 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Clover Health Investments Corp Common stock | $6.5K | +1K +2.73% | 46,817 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Unity Software Inc. Common stock | $6.5K | +298 +0.35% | 86,635 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Xeris Biopharma Holdings, Inc. Common stock | $6.7K | +841 +4.59% | 19,172 <0.01% of portfolio | low |
| Q2 2026 as of | Add | SentinelOne, Inc. Common stock | $6.7K | +394 +1.08% | 36,876 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Starwood Property Trust, Inc. Common stock | $6.7K | +412 +0.75% | 55,331 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Newell Brands Inc. Common stock | $6.9K | +1K +1.69% | 67,449 <0.01% of portfolio | low |
| Q2 2026 as of | Add | AMAL Amalgamated Financial Corp. Common Stock | $6.9K | +150 +0.17% | 90,374 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Palisade Bio, Inc. Common stock | $6.9K | +3K +20.07% | 19,757 <0.01% of portfolio | low |
| Q1 2026 as of | Add | ASP Isotopes Inc. Common stock | $6.9K | +2K +13.99% | 12,806 <0.01% of portfolio | low |
| Q1 2026 as of | Add | MLYS Mineralys Therapeutics Inc Common Stock | $7.0K | +260 +0.79% | 33,141 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Advance Auto Parts Inc Common stock | $7.2K | +116 +1.19% | 9,833 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Madrigal Pharmaceuticals, Inc. Common stock | $7.3K | +14 +0.24% | 5,836 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Cleveland-Cliffs Inc. Common stock | $7.3K | +781 +0.87% | 90,850 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Vestis Corp Common stock | $7.4K | +508 +2.58% | 20,185 <0.01% of portfolio | low |
| Q2 2026 as of | Add | CAR Avis Budget Group, Inc. Common Stock | $7.7K | +52 +1.10% | 4,777 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Avantor, Inc. Common stock | $7.7K | +778 +0.73% | 107,881 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Financial Institutions Inc Common stock | $7.8K | +200 +0.53% | 37,800 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Viking Therapeutics Inc Common stock | $7.9K | +202 +1.57% | 13,048 <0.01% of portfolio | low |
| Q1 2026 as of | Add | RES Rpc Inc Common Stock | $7.9K | +1K +2.22% | 51,311 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Resideo Technologies, Inc. Common stock | $8.0K | +256 +0.47% | 54,656 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Solid Power, Inc. Common stock | $8.1K | +3K +15.27% | 23,614 <0.01% of portfolio | low |
| Q2 2026 as of | Add | LUCD Lucid Diagnostics Inc. Common Stock | $8.2K | +8K +75.49% | 17,747 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Lightwave Logic, Inc. Common stock | $8.4K | +1K +7.86% | 16,374 <0.01% of portfolio | low |
| Q2 2026 as of | Add | STGW Stagwell Inc Common Stock | $8.4K | +1K +0.60% | 189,931 <0.01% of portfolio | low |